Home > Drug Search >
  • company_query: Andarix
  •   > 
Drug Filter
Category:
chemistry (20) biology (3)
Status:
Approved (2) NDA Filing (1) Phase Ⅲ (3) Phase Ⅱ (7) Phase Ⅰ (9) IND Filing (1)
Clinical Stage:
Pending (2) Active (14) Discontinued (5)
Bio-Type:
Vaccine (2) Fusion protein (1)
Indication:
Alzheimer's disease (AD) (1) Breast cancer (1) Transplant rejection (1) Epilepsy/Seizures (1) HCV infection (2) Hepatocellular carcinoma (HCC) (1) Influenza virus infection (1) Lung cancer (1) Myocardial infarction (MI) (1) Neuropathic pain (1) Non small cell lung cancer (NSCLC) (2) Pancreatic cancer (1) Peripheral arterial disease (PAD) (1) Rheumatoid arthritis (RA) (1) Sensitive anaerobic bacteria infections (1) Solid tumours (1) Urinary tract infections (1) Colorectal cancer (1) Malaria (1) Kaposi's sarcoma (1) Glioma (1) Thrombosis (1) Diabetic neuropathy (1) Liver cancer (1) Arterial occlusive disease (1) Coronary restenosis (1) Infectious disease (1) Ebola virus disease (EVD) (1) Inflammatory pain (1)
Country:
Aprv. Year:
 (1) 2009 (1) 2010 (1)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 2 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top